Stocks and Investing
Stocks and Investing
Tue, July 11, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jason Butler Reiterated (VRDN) at Buy and Held Target at $44 on, Jul 11th, 2023
Jason Butler of JMP Securities, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $44 on, Jul 11th, 2023.
Jason has made no other calls on VRDN in the last 4 months.
There are 4 other peers that have a rating on VRDN. Out of the 4 peers that are also analyzing VRDN, 0 agree with Jason's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jason
- Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023
- Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023
- Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $40 on, Wednesday, May 10th, 2023
- Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $49 on, Thursday, March 30th, 2023
Contributing Sources